<h4>Background</h4>Colorectal cancer (CRC) is a major health burden globally and in China, where 3%-5% of cases involve the BRAF<sup>V600E</sup> mutation, which is associated with aggressive disease and therefore a poor prognosis. Here, BRAF is linked to colorectal carcinoma.